Maine LD 697: An Act To Direct The Maine Prescription Drug Affordability Board To Assess Strategies To Reduce Prescription Drug Costs And To Take Steps To Implement Reference-Based Pricing

Status: Became Law without Governor's Signature (as of 2026-01-11)

State: Maine · Session: 132 · Bill: LD 697

Subjects: AFFORDABILITY BOARD, COST REDUCTION STRATEGIES, PRESCRIPTION DRUGS

Sponsors: Cameron RENY, Denise TEPLER, Donna BAILEY, Henry INGWERSEN, Joseph RAFFERTY, Kristi MATHIESON

View Maine LD 697 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.